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Background: T1 mapping with cardiac magnetic resonance (CMR) is already validated for the quantification of interstitial fibrosis. We aimed 
at further exploring associations between myocardial post-contrast T1 reductions as a surrogate for interstitial fibrosis with left ventricular (LV) 
structure and function in non-ischemic dilated cardiomyopathy (NIDCM).
methods: Patients with NIDCM and LV ejection fraction (LVEF) ≤40% referred for CMR evaluation were retrospectively identified. T1 times were 
obtained after the administration of gadolinium from the interventricular septum by a validated Look-Locker sequence. LV end-systolic and end-
diastolic volumes, LV mass, LVEF, and presence of late gadolinium enhancement (LGE) were calculated from standard images.
results: We included 113 patients (75 males [67%], age 58 ± 16 years, mean LVEF: 26.5 ± 8.1%). Reduced T1 times were associated with 
decreases in LVEF and increases in LV end systolic volumes, LV end diastolic volumes, and LV mass (Table). When the analysis was restricted to 
patients without LGE (n=18), these correlations remained significant (Table). 
Table: T1 interventricular septum correlations
All patients LGE (-) patients
Variable (r) coefficient p-value (r) coefficient p-value
LVEF (%) 0.47 <0.001 0.76 <0.001
LVESV (ml) -0.37 <0.001 -0.53 0.023
LVEDV (ml) -0.24 0.01 -0.32 ns
LV Mass (g) -0.27 0.005 -0.49 0.047
Abbreviations: 
LVEF - left ventricular ejection fraction; LVESV - left ventricular end systolic volume; LVEDV - left ventricular end diastolic volume; LV mass - left 
ventricular mass; LGE - late gadolinium enhancement; ns = not significant
conclusions: Reduction in post-contrast myocardial T1, a surrogate of diffuse interstitial fibrosis, is associated with LV systolic dysfunction, 
dilatation and hypertrophy in NIDCM.
